
Dx Deal Roundup: Top 10 Clinical Lab M&A Deals of 2023
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.
While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.
As is usual at this time of year, deals in the diagnostics industry were up, both in terms of volume and value.
April was among the busiest months, in recent memory, in terms of both deal volume and significance in the diagnostics industry.
Thermo Fisher, Helix, and Rosalind collaborate on an NIH-supported project to develop a new genotyping method to ID virus variants faster.